Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	24
2.2 Major Growth Drivers	26
2.3 Market Restraints and Challenges	34
2.4 Emerging Opportunities and Market Trends	37
2.5 Porter’s Fiver Forces Analysis	41
3 Segmentation of North America Market by Offering	45
3.1 Market Overview by Offering	45
3.2 Products	47
3.3.1 Probiotics	48
3.3.2 Prebiotics	49
3.3.3 Vitamins & Supplements	50
3.3 Testing Services	51
3.3.1 Nutrigenomics Clinical Testing	52
3.3.2 Nutrigenomics Research Testing	53
4 Segmentation of North America Market by Test Technology	54
4.1 Market Overview by Test Technology	54
4.2 Next-generation Sequencing	56
4.3 Real-time PCR	57
4.4 DNA Microarray	58
4.5 Sanger Sequencing	59
5 Segmentation of North America Market by Test Sample	60
5.1 Market Overview by Test Sample	60
5.2 Buccal Swab Sample	62
5.3 Saliva Sample	63
5.4 Blood Sample	64
5.5 Other Samples	65
6 Segmentation of North America Market by Application	66
6.1 Market Overview by Application	66
6.2 Women’s Health	68
6.3 Metabolic Disorders	69
6.4 Immune Health	70
6.5 Cancer Research	71
6.6 Cardiovascular Diseases	72
6.7 Diabetes	73
6.8 Other Applications	74
7 Segmentation of North America Market by End User	75
7.1 Market Overview by End User	75
7.2 Hospitals	77
7.3 Nutrition Clinics	78
7.4 Diagnostics Laboratories	79
7.5 Other End Users	80
8 North America Market 2021-2031 by Country	81
8.1 Overview of North America Market	81
8.2 U.S.	84
8.3 Canada	87
8.4 Mexico	89
9 Competitive Landscape	91
9.1 Overview of Key Vendors	91
9.2 New Product Launch, Partnership, Investment, and M&A	94
9.3 Company Profiles	95
BASF SE	95
BioGaia	97
Cell Logic	98
Cura Integrative Medicine	99
DNAfit	100
DuPont de Nemours, Inc.	101
Garden of Life, LLC	102
GeneOmbio	103
Genova Diagnostics, Inc.	104
GX Sciences, Inc.	105
Ingredion Incorporated	106
Jarrow Formulas Inc.	107
Koninklijke DSM N.V.	108
MedGenome	109
Metagenics, Inc.	110
Nutrigenomix Inc.	111
Unilever Group	112
XCODE Life	113
Yakult Honsha Co., Ltd.	114
RELATED REPORTS	115
?

List of Tables:

Table 1.  Snapshot of North America Nutrigenomics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	33
Table 5.  Main Product Trends and Market Opportunities in North America Nutrigenomics Market	37
Table 6. North America Nutrigenomics Market by Offering, 2021-2031, $ mn	45
Table 7. North America Nutrigenomics Market: Products by Type, 2021-2031, $ mn	47
Table 8. North America Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn	51
Table 9. North America Nutrigenomics Market by Test Technology, 2021-2031, $ mn	54
Table 10. North America Nutrigenomics Market by Test Sample, 2021-2031, $ mn	60
Table 11. North America Nutrigenomics Market by Application, 2021-2031, $ mn	66
Table 12. North America Nutrigenomics Market by End User, 2021-2031, $ mn	75
Table 13. North America Nutrigenomics Market by Country, 2021-2031, $ mn	82
Table 14. U.S. Nutrigenomics Market by Offering, 2021-2031, $ mn	86
Table 15. U.S. Nutrigenomics Market by Application, 2021-2031, $ mn	86
Table 16. U.S. Nutrigenomics Market by End User, 2021-2031, $ mn	86
Table 17. Canada Nutrigenomics Market by Offering, 2021-2031, $ mn	88
Table 18. Canada Nutrigenomics Market by Application, 2021-2031, $ mn	88
Table 19. Canada Nutrigenomics Market by End User, 2021-2031, $ mn	88
Table 20. Mexico Nutrigenomics Market by Offering, 2021-2031, $ mn	90
Table 21. Mexico Nutrigenomics Market by Application, 2021-2031, $ mn	90
Table 22. Mexico Nutrigenomics Market by End User, 2021-2031, $ mn	90
Table 23. BASF SE: Company Snapshot	95
Table 24. BASF SE: Business Segmentation	96
Table 25. BASF SE: Product Portfolio	96

List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. North America Nutrigenomics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	24
Figure 6. Primary Drivers and Impact Factors of North America Nutrigenomics Market	26
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million	29
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	31
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	32
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	32
Figure 11. Primary Restraints and Impact Factors of North America Nutrigenomics Market	34
Figure 12. Investment Opportunity Analysis	38
Figure 13. Porter’s Fiver Forces Analysis of North America Nutrigenomics Market	41
Figure 14. Breakdown of North America Nutrigenomics Market by Offering, 2021-2031, % of Revenue	46
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	46
Figure 16. North America Nutrigenomics Market by Offering: Products, 2021-2031, $ mn	47
Figure 17. North America Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn	48
Figure 18. North America Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn	49
Figure 19. North America Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn	50
Figure 20. North America Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn	51
Figure 21. North America Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn	52
Figure 22. North America Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn	53
Figure 23. Breakdown of North America Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue	55
Figure 24. North America Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%)	55
Figure 25. North America Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn	56
Figure 26. North America Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn	57
Figure 27. North America Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn	58
Figure 28. North America Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn	59
Figure 29. Breakdown of North America Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue	61
Figure 30. North America Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%)	61
Figure 31. North America Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn	62
Figure 32. North America Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn	63
Figure 33. North America Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn	64
Figure 34. North America Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn	65
Figure 35. Breakdown of North America Nutrigenomics Market by Application, 2021-2031, % of Revenue	67
Figure 36. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	67
Figure 37. North America Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn	68
Figure 38. North America Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn	69
Figure 39. North America Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn	70
Figure 40. North America Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn	71
Figure 41. North America Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn	72
Figure 42. North America Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn	73
Figure 43. North America Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn	74
Figure 44. Breakdown of North America Nutrigenomics Market by End User, 2021-2031, % of Revenue	76
Figure 45. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	76
Figure 46. North America Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn	77
Figure 47. North America Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn	78
Figure 48. North America Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn	79
Figure 49. North America Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn	80
Figure 50. Breakdown of North America Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	82
Figure 51. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	83
Figure 52. U.S. Nutrigenomics Market, 2021-2031, $ mn	85
Figure 53. Canada Nutrigenomics Market, 2021-2031, $ mn	87
Figure 54.  Nutrigenomics Market in Mexico, 2021-2031, $ mn	89
Figure 55. Growth Stage of North America Nutrigenomics Industry over the Forecast Period	91

Selected Key Players: 
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)